Physician profile
Christopher Lee Wright
NPI 1215304696
$297.82
in general payments reported to CMS, 2019-2025
8 companies · $14.83 in 2025
The $14.83 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $236 · 2022: $47.13 · 2025: $14.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $88.34 | 2021-2022 | |
| Abbvie INC. | $75.15 | 2021 | |
| Nestle Healthcare Nutrition INC. | $40.81 | 2021 | |
| Merck Sharp & Dohme LLC | $40.30 | 2021 | |
| Amgen INC. | $14.83 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.64 | 2021 | |
| Intercept Pharmaceuticals, INC. | $12.15 | 2021 | |
| Redhill Biopharma INC. | $11.60 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.